GlaxoSmithKline S.A.E (EGX: BIOC)
Egypt
· Delayed Price · Currency is EGP 40.58
-0.16 (-0.39%)
At close: Nov 21, 2024
GlaxoSmithKline S.A.E Market Cap
GlaxoSmithKline S.A.E has a market cap or net worth of 3.39 billion as of November 22, 2024. Its market cap has increased by 22.78% in one year.
Market Cap
3.39B
Enterprise Value
3.26B
Revenue
2.81B
Ranking
n/a
PE Ratio
28.40
Stock Price
40.58
Market Cap Chart
Since August 23, 2005, GlaxoSmithKline S.A.E's market cap has increased from 569.45M to 3.39B, an increase of 495.13%. That is a compound annual growth rate of 9.70%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition